Conjugate having a cleavable linkage for use in a liposome

Details Conjugate having a cleavable linkage for use in a liposome Conjugate having a cleavable linkage for use in a liposome

2007-10-02

2007-10-02

Riley, Jezia (Department: 1637)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Liposomes

C424S085100, C205S254000, C530S336000, C536S084000, C514S001000

Reexamination Certificate

active

11202913

ABSTRACT:
Conjugates of a hydrophobic moiety, such as a lipid, linked through a cleavable dithiobenzyl linkage to a therapeutic agent are described. The dithiobenzyl linkage is susceptible to cleavage by mild thiolysis, resulting in release of the therapeutic agent in its original form. The linkage is stable under nonreducing conditions. The conjugate can be incorporated into liposomes for administration in vivo and release of the therapeutic agent in response to endogeneous in vivo reducing conditions or in response to administration of an exogeneous reducing agent.

REFERENCES:
patent: 4021449 (1977-05-01), Fujimoto et al.
patent: 4179337 (1979-12-01), Davis et al.
patent: 4766106 (1988-08-01), Katre et al.
patent: 4902502 (1990-02-01), Nitecki et al.
patent: 4917888 (1990-04-01), Katre et al.
patent: 4935465 (1990-06-01), Garman
patent: 5103556 (1992-04-01), Filip et al.
patent: 5169934 (1992-12-01), Clark et al.
patent: 5395619 (1995-03-01), Zalipsky et al.
patent: 5560923 (1996-10-01), Rahman et al.
patent: 5631018 (1997-05-01), Zalipsky et al.
patent: 5648090 (1997-07-01), Rahman et al.
patent: 5891468 (1999-04-01), Martin et al.
patent: 6180095 (2001-01-01), Greenwald et al.
patent: 6342244 (2002-01-01), Zalipsky
patent: 6365179 (2002-04-01), Zalipsky et al.
patent: 6605299 (2003-08-01), Zalipsky
patent: 6638500 (2003-10-01), El-Tayar et al.
patent: 6849270 (2005-02-01), Zalipsky
patent: 6984396 (2006-01-01), Zalipsky et al.
patent: 2004/0213579 (2004-10-01), Zalipsky et al.
patent: 0 317 956 (1989-05-01), None
patent: 0 317 957 (1989-05-01), None
patent: 0 510 197 (1992-10-01), None
patent: 0 898 968 (1999-03-01), None
patent: 2 254 336 (1975-07-01), None
patent: 1113391 (1989-05-01), None
patent: WO97/36904 (1997-10-01), None
patent: WO98/16201 (1998-04-01), None
patent: WO99/29302 (1999-06-01), None
patent: WO 00/64483 (2000-11-01), None
patent: WO 00/64484 (2000-11-01), None
patent: WO 01/26629 (2001-04-01), None
patent: WO 02/26265 (2002-04-01), None
patent: WO 03/053409 (2003-07-01), None
patent: WO 2004/110497 (2004-12-01), None
Briddell et al.,Blood, 102(11):163b-164b (1999).
Database Dissertation Abstracts [Online] Proquest Info & Learning; Woghiren, Clement O. et al.: “Synthesis, Characterization and Conjugation of a Novel Protected Thiol-Polyethylene Glycol: A New Activated Polymer for Reversible Protein Modification (IL-2)” Dialog Accession No. 01367093; Dissertation Abstracts 55(03-B), 1994, p. 866.
Johnson et al.,Chemistry and Biology, 4(12):939-950 (1997).
Kratz et al., J. Med.Chemistry, 45(12):5523-5533 (2002).
Malik et .,Experimental Hematology, 28(7, Suppl. 1):106, Abstract No. 237 (2000).
Thorpe et al.,Cancer Res., 47(12):5924-5931 (1987).
Worrell et al.,Anticancer Drug Design, 1(12):179-188 (1986).
Zalipsky, S., et al., 28thInternational Symposium on Controlled Release of Bioactive Materials and 4thConsumer & Diversified Products Conference, San Diego, CA, Publisher: Controlled Release Society 1:437-438, (2001).
Ellman, G.I., Arch. Biochem. Biophys., 82:70-77 (1959).
Engman et al., Bioorganic & Medical Chemistry, 11:5091-5100 (2003).
Grassetti and Murray, Arch. Biochem. Biophys., 119(1):41-49 (1967).
Asai, T., et al.,Biol Pharm Bull 21(7):766-771, (1998).
Brois, S.J., et al.,J. Amer. Chem. Soc. 92(26):7629-7631 (1970).
Diaz, C., et al.,Bioconjugate Chem 9(2):250-254, (1998).
Dittmer, J.C., et al.,J. Lipid Res. 126-127 (1964).
Gaber, M., et al.,Pharmaceutical Res 12(10):1407-1416, (1995).
Grice, R., et al.,J. Chem. Soc. 1947-1954 (1963).
Hirota, S.,International J of Pharmaceutics 162(1-2):185-194, (1998).
Johnsson, M., et al.,J of Liposome Res 9(1):53-79, (1999).
Kaneko, T., et al.,Bioconjugate Chem. 2(3):133-141 (1991).
Kirpotin, D., et al.,FEBS Letters 388:115-118, (1996).
Lash, L.H., et al.,Arch. Biochem. Biophys. 240(2):583-592 (1985).
Mueller, C.E., et al., 322(6):343-350, (1989).
Senter, P.D., et al.,J Org Chem 55(9):2975-2978, (1990).
Vaage, J., et al.,Cancer 72(12):3671-3675, (1993).
Vaage, J., et al.,Cancer 73(5):1478-1484, (1994).
Vaage, J., et al.,International J of Cancer 51(6)942-948, (1992 ).
Veronese, et al.,Applied Biochem. And Biotech. 141-152 (1985).
Zalipsky, et al.,Biotechnol. Appl. Biochem. 100-114 (1992).
Zalipsky, et al.,Eur. Polymer. J. 19(12):1177-1183 (1983).
Zalipsky, et al.,Bioconj. Chem. 4(4):296-299 (1993).
Zalipsky,Bioconj Chem 10(5):703-707, (1999).
Waalkis, Selective Cancer Therapeutics 21(7):766-771, (1998).
International Journal of Cancer 80(1):134-137, (1997).
Vaage, J., et al.,International J of Cancer 51(6)942-948, (1992).
Thierry et al.,FASEB, 6:572-579 (1993).
Warren et al.,Cancer Research, 52:3241-3245 (1992).

Affiliated with

Also associated with

Rating

Conjugate having a cleavable linkage for use in a liposome does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Conjugate having a cleavable linkage for use in a liposome, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Conjugate having a cleavable linkage for use in a liposome will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3867485